Semaglutide - a glucagon-like peptide-1 (GLP-1) receptor agonist medication used to improve blood sugar control and promote weight loss. It mimics the incretin hormone GLP-1 to:
Suppress inappropriate glucagon release from alpha cells.
Slow gastric emptying, reducing postprandial glucose spikes and appetite.
Reduce food intake via central appetite-regulating pathways.
Typical adverse effects: nausea, vomiting, constipation, abdominal pain; less commonly pancreatitis, gallbladder disease, and possible risk of medullary thyroid carcinoma in susceptible patients (boxed warning in some regions). Dose titration will be used to improve tolerability.
ADDED: L-CARNITINE
A naturally occurring compound involved in fatty acid transport into mitochondria for energy production.
Common uses
Supplemental support for exercise performance, fat metabolism, fatigue, age-related muscle loss, andcertain medical conditions (e.g., primary/secondary carnitine deficiency).
Semaglutide - a glucagon-like peptide-1 (GLP-1) receptor agonist medication used to improve blood sugar control and promote weight loss. It mimics the incretin hormone GLP-1 to:
Suppress inappropriate glucagon release from alpha cells.
Slow gastric emptying, reducing postprandial glucose spikes and appetite.
Reduce food intake via central appetite-regulating pathways.
Typical adverse effects: nausea, vomiting, constipation, abdominal pain; less commonly pancreatitis, gallbladder disease, and possible risk of medullary thyroid carcinoma in susceptible patients (boxed warning in some regions). Dose titration will be used to improve tolerability.
ADDED: L-CARNITINE
A naturally occurring compound involved in fatty acid transport into mitochondria for energy production.
Common uses
Supplemental support for exercise performance, fat metabolism, fatigue, age-related muscle loss, andcertain medical conditions (e.g., primary/secondary carnitine deficiency).